All Type of News
Genexol inj. applicable to stomach cancer as additional indication
Samyang Corporation said that Genexol (paclitaxel) inj., a chemotherapy that is given as a treatment for some types of cancer such as ovarian, breast and non-small cell lung cancer, was approved from the Korea Food an...
Ursa showing brisk monthly sales
Daewoong Pharm said recently that Ursa (ursodeoxycholic acid; UDCA) capsule, which has been locally recognized as one of the most popular liver protectives for the past 40 years, has witnessed bigger monthly sales of ...
Europeans community to censure MOHW for drug pricing policies.
European Chamber of Commerce of Korea took a press interview at Yeongbin hall of Shilla hotel at 10 a.m. on March 3 under the title of "2004 trade barrier report", pointing out that the Korean government gave special ...
Binex filed IND for a new colon cancer drug.
Binex (President: Lee Baek-cheon) announced that an investigational new drug application (IND) for DC-Vac/IR, a new colon cancer injectable drug, was submitted to KFDA on March 2.
DE-Vac/IR is a new immunological ...
Choong-wae Pharm inks tie-up with MarukoChoong-wae Pharm said on March 2 that it signed a joint partnership with Japan's Maruko Seiyaku Co, one of Japan's leading pharmaceutical makers, to license out its newly develo...
|
Kwangdong Pharm gains foothold in vitamin drink market
With less than a three-year-old Vita-500 drink preparation after launching, Kwangdong Pharm is now moving to accelerate its bid to grasp an initiative in the domestic nutritional drink and tonic markets by making heav...
KFDA approves additional indication of Seroquel
AstraZeneca Korea said recently it has received from the Korea Food and Drug Administration an additional indication of Seroquel (quetiapine), which is available at 25mg, 100 mg and 200 mg, for the treatment of acute ...
Pharmacy markets in deep depression.
Pharmacy management has been seriously deteriorated these days compared to the past years, showing almost 30% of sales down as a result of overall declined number of patients, ever slowed consumer's spending and a war...
2006 international drug regulatory conference taking place in Korea.
The 12th International Conference of Drug Regulatory Authorities (ICDRA) may take place in Korea in 2006 according to Dr. Shim Chang-koo, chief commissioner of KFDA.
Dr. Shim announced that in the 11th ICDRA in Mad...
Chong Kun Dang launches Camtobell injection, camptothecin analogue topoisomerase I inhibitorChong Kun Dang Pharmaceutical Co. said it launched Korea's 8th new drug Camtobell injection for the treatment of ovarian cancer (second-line therapy) and small-cell lung cancer ...
|
